Daiichi Sankyo Company, Limited (Japanese: 第一三共株式会社, Hepburn: Daiichi Sankyō Kabushiki-gaisha) is a global pharmaceutical company and the second-largest...

the course of its history. In 2008, Japanese pharmaceutical company Daiichi Sankyo acquired a controlling share in Ranbaxy and in 2014, Sun Pharma acquired...

Sankyo (三共, Sankyō) means "third one" in Japanese. It may refer to: Daiichi Sankyo Co. (第一三共, Daiichi Sankyō), a Japanese pharmaceutical company and a...

developmental code name DS-5565) is a gabapentinoid medication developed by Daiichi Sankyo. Gabapentin and pregabalin are also members of this class. As a gabapentinoid...

agreement with Daiichi Sankyo to distribute Nexium in Japan. In September 2011, Nexium was approved for sale and was launched by Daiichi Sankyo in Japan. Esomeprazole...

Office Tower Y in Chūō. Daiichi Sankyo, a global pharmaceutical company is also headquartered in the ward, in the Daiichi Sankyo Building. Oji Paper Holdings...

the company announced it would co-commercialise naloxegol along with Daiichi Sankyo in a deal worth up to US$825 million. Towards the end of April the company...

identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently marketed in Japan by Daiichi Sankyo under...

treated with subcutaneous injection of ABBV-154 is ongoing. In July 2018, Daiichi Sankyo Company, Limited and Glycotope GmbH have inked a pact regarding the...

company's buyers when he mediated its sale to the Japanese drugmaker Daiichi Sankyo, in 2008.: 316ff, 398f  Singh, who had been kept on as CEO by the purchasing...

pharmaceutical company Daiichi Sankyo for $805 million and an additional $130 million in potential milestone payments. Daiichi Sankyo announced the shutdown...

and Enix - Merged to form Square Enix Daiichi Pharmaceutical Co. and Sankyo Co. - Merged to form Daiichi Sankyo Takata Corporation - went bankrupt then...

antimineralocorticoid which was discovered by Exelixis and developed by Daiichi Sankyo Company and is approved in Japan for the treatment of hypertension....

2002. Olmesartan and Sevikar HCT combined is marketed worldwide by Daiichi Sankyo, in India by Abbott Healthcare Pvt. Ltd. under the trade name WinBP...

Shanghvi became managing director. In April 2014 Sun, Ranbaxy, and Daiichi Sankyo (the majority shareholder in Ranbaxy) agreed that Sun would acquire...

followed by Amgen, F. Hoffmann-La Roche AG, Janssen Pharmaceutica, Daiichi Sankyo, Sanofi-Aventis, Bristol-Myers Squibb and AstraZeneca. He was a director...

Azelnidipine is L and T calcium channel blocker. It is sold in Japan by Daiichi-Sankyo pharmaceuticals, Inc. Unlike nicardipine, it has a gradual onset and...

Kyiv, Ukraine. The company is part of the multinational corporation Daiichi Sankyo. Terapia Ranbaxy produces a wide range of medicines and drugs, mostly...

is currently marketed under the name Inavir by Daiichi Sankyo. Biota Pharmaceuticals and Daiichi Sankyo co-own Laninamivir. On 1 April 2011, BARDA awarded...

the NASDAQ exchange under the symbol "AMBI". Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange. As of March 2014[update]...

release: Daiichi Sankyo Initiates Phase 3 study of CS-3150, a Novel Mineralocorticoid Receptor Antagonist for Treatment of Essential Hypertension". Daiichi Sankyo...

Citizen Holdings Comsys Concordia Financial Credit Saison Dai-ichi Life Daiichi Sankyo Daikin Daiwa House Daiwa Securities Denka Denso Dentsu DNP Dowa Ebara...

Cyclacel (1997– ) Cytokinetics (1997– ) CytRx (1985– ) Daewoong (1945– ) Daiichi Sankyo (2005– ) Danco (2000– ) Darou Pakhsh (1956– ) Dawa (1994– ) Debiopharm...

MK-1022) is an experimental antibody–drug conjugate developed by Merck and Daiichi Sankyo to treat non-small-cell lung cancer. Yu, H.A.; Baik, C.S.; Gold, K.;...

for use in the treatment of type 2 diabetes. It is being developed by Daiichi Sankyo. Schimke K, Davis TM (April 2007). "Drug evaluation: rivoglitazone,...

Pharma Inc. (TYO: 4503) Chugai Pharmaceutical Co., Ltd. (TYO: 4519) Daiichi Sankyo Company, Limited (TYO: 4568) Eisai Co., Ltd. (TYO: 4523) Kyowa Hakko...

Compared with warfarin it has fewer drug interactions. It was developed by Daiichi Sankyo and approved in July 2011, in Japan for prevention of venous thromboembolisms...

Premium, with apronal, caffeine, and aluminium magnesium silicate. Daiichi Sankyo Co. (January 24, 2006). "Percutaneous Absorption-Type Analgesic and...

Gottlieb was an independent director at Tolero Pharmaceuticals and Daiichi Sankyo Inc. and a member of GlaxoSmithKline's product investment board, which...

1 October 1991, assigned to Daiichi Sankyo Co Ltd.  Atarashi S. "Research and Development of Quinolones in Daiichi Sankyo Co" (PDF). Archived from the...